Widschwendter, M;
Burnell, M;
Fraser, L;
Rosenthal, AN;
Philpott, S;
Reisel, D;
Dubeau, L;
... Dougall, WC; + view all
(2015)
Osteoprotegerin (OPG), the endogenous inhibitor of receptor activator of NF-κB ligand (RANKL), is dysregulated in BRCA mutation carriers.
EBioMedicine
, 2
(10)
pp. 1331-1339.
10.1016/j.ebiom.2015.08.037.